TGF-β was the major factor in the failure of filtering blebs; thus, ROCK inhibitors such as AR12286 could be candidates that suppress TGF-β pathways and serve as an adjunctive agent to reduce the failure rate of glaucoma filtering surgeries. The gene discussed is TGFB1; the disease is glaucoma.